Impact of COVID-19 mitigations on anxiety and depression amongst university students: A systematic review and meta-analysis

Individual Author(s) / Organizational Author
Lee, Bohee
Krishan, Prerna
Goodwin, Lara
Iduye, Damilola
Farfan de Los Godos, Emma
Fryer, Jodie
Gallagher, Katie
Hair, Kaitlyn
O'Connell, Eimear
Ogarrio, Kristen
King, Theresa
Sarica, Shifa
Scott, Eileen
Song, Peige
Dozier, Marshall
McSwiggen, Emile
Li, Xue
Stojanovski, Kristefer
Theodoratou, Evropi
McQuillan, Ruth
UNCOVER Group
Publisher
PubMed
Date
September 2023
Abstract / Description

Background: While much research has addressed mental health concerns related to the coronavirus disease 2019 (COVID-19) pandemic, there remains a scarcity of studies specifically exploring the changes in anxiety and depression among university students before and after the implementation of COVID-19 mitigation measures.

Methods: In this systematic review and meta-analysis, we searched databases including MEDLINE (Ovid), EMBASE (Ovid), PsycINFO (Ovid), CINAHL (EBSCO), ERIC (EBSCO), the WHO COVID-19 database, Scopus, and Science Citation Index (Web of Science) as of 15 February 2023. We included studies that used a validated tool to measure changes in anxiety or depression at two distinct time points - before (T1) and during (T2); during (T2) and after (T3); or before (T1) and after (T3) COVID-19 mitigation. The quality of studies was assessed using an adapted Joanna Briggs Institute Checklist for longitudinal studies. Utilising random-effects models, we synthesised changes in continuous outcomes as standardised mean difference (SMD) with 95% confidence interval (CI) and binary outcomes as risk difference (RD) with 95% CI.

Results: In total, 15 studies were included in this review, with eight of moderate and seven of high quality. In most of the included studies (n = 13), the majority of participants were women. Eleven studies analysed mental health outcomes between T1 and T2 of COVID-19 mitigations. Continuous symptom changes were a minimal or small improvement for anxiety (SMD = -0.03, 95% CI = -0.24 to 0.19, I2 = 90%); but worsened for depression (SMD = 0.26, 95% CI = -0.01 to 0.62). However, the proportions of students reporting moderate-to-severe symptoms, defined by specific cut-offs, increased during COVID-19 mitigation measures for both anxiety (RD = 0.17, 95% CI = -0.04 to 0.38, I2 = 95%) and depression (RD = 0.12, 95% CI = 0.03 to 0.22, I2 = 72%). Sensitivity analyses, which distinguished between baseline periods based on awareness of COVID-19, demonstrated an exacerbation of both symptoms when comparing the period before the global awareness of the COVID-19 outbreak (before December 2019) with the period during the implementation of mitigation measures.

Conclusions: Mental health outcomes, especially depressive symptoms, were observed to worsen in university students during COVID-19 mitigations. Despite considerable heterogeneity requiring careful interpretation of results, the impact of COVID-19 mitigations on mental health in university students is evident. (Author abstract)

#P4HEworkshopSynthesis

Artifact Type
Research
Reference Type
Journal Article
Topic Area
Illness/Disease/Injury/Wellbeing » Communicable Disease » COVID-19/Coronavirus
Illness/Disease/Injury/Wellbeing » Mental/Behavioral Health » Depression